Cytochrome P450 2C19 Poor Metabolizer Phenotype in Treatment Resistant Depression: Treatment and Diagnostic Implications.
Veldic M, Ahmed AT, Blacker CJ, Geske JR, Biernacka JM, Borreggine KL, Moore KM, Prieto ML, Vande Voort JL, Croarkin PE, Hoberg AA, Kung S, Alarcon RD, Keeth N, Singh B, Bobo WV, Frye MA.
Veldic M, et al. Among authors: singh b.
Front Pharmacol. 2019 Feb 19;10:83. doi: 10.3389/fphar.2019.00083. eCollection 2019.
Front Pharmacol. 2019.
PMID: 30837869
Free PMC article.